The store will not work correctly when cookies are disabled.
2-(1-(Benzylcarbamoyl)-4-oxoazetidin-2-yl)acetic Acid
ID: ALA4755971
PubChem CID: 162655936
Max Phase: Preclinical
Molecular Formula: C13H14N2O4
Molecular Weight: 262.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CC1CC(=O)N1C(=O)NCc1ccccc1
Standard InChI: InChI=1S/C13H14N2O4/c16-11-6-10(7-12(17)18)15(11)13(19)14-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,19)(H,17,18)
Standard InChI Key: XTNLRPMBRFOVIZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
13.7230 -16.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7230 -16.9340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5402 -16.9340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5402 -16.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1452 -17.5118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1180 -17.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9065 -18.3012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9074 -17.3003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1180 -15.5390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9065 -14.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4825 -14.1722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1153 -14.5385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4852 -17.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2746 -17.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8482 -18.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6369 -18.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8491 -17.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2664 -16.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4799 -16.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
2 5 2 0
3 6 1 0
6 7 2 0
6 8 1 0
4 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
8 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.26 | Molecular Weight (Monoisotopic): 262.0954 | AlogP: 0.97 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.71 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.04 | CX Basic pKa: ┄ | CX LogP: 0.51 | CX LogD: -2.63 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.79 | Np Likeness Score: -0.53 |
References
1. Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D. (2016) New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins., 59 (21): [PMID:27726366] [10.1021/acs.jmedchem.6b00576] |